Phenotyping Study of Cyclophosphamide 4-Hydroxylation in Malay Cancer Patients

QUANTIFICATION OF 3-HYDROXYPROPYL MERCAPTURIC ACID IN THE URINE OF PATIENTS WITH BREAST CANCER TO MONITOR CYCLOPHOSPHAMIDE TOXICITY

(2020) Yahdiana Harahap et al.   THERAPEUTIC DRUG MONITORING

A sensitive and rapid ultra high-performance liquid chromatography with tandem mass spectrometric assay for the simultaneous quantitation of cyclophosphamide and the 4-hydroxycyclophosphamide metabolite in human plasma

(2018) O. Morgan Hall et al.   JOURNAL OF CHROMATOGRAPHY B-ANALYTICAL TECHNOLOGIES IN THE BIOMEDICAL AND LIFE SCIENCES

To Genotype or Phenotype for Personalized Medicine? CYP450 Drug Metabolizing Enzyme Genotype–Phenotype Concordance and Discordance in the Ecuadorian Population

(2016) Fernando De Andrés et al.   OMICS-A JOURNAL OF INTEGRATIVE BIOLOGY

Effects of CYP2B6 genetic polymorphisms in patients receiving cyclophosphamide combination chemotherapy for breast cancer

(2014) F. Haroun et al.   CANCER CHEMOTHERAPY AND PHARMACOLOGY

Pharmacogenetics of cytochrome P450 2B6 (CYP2B6): advances on polymorphisms, mechanisms, and clinical relevance

(2013) Ulrich M. Zanger et al.   Frontiers in Genetics

Cyclophosphamide and 4-hydroxycyclophosphamide pharmacokinetics in patients with glomerulonephritis secondary to lupus and small vessel vasculitis

(2012) Melanie S. Joy et al.   BRITISH JOURNAL OF CLINICAL PHARMACOLOGY

Allelic variations in CYP2B6 and CYP2C19 and survival of patients receiving cyclophosphamide prior to myeloablative hematopoietic stem cell transplantation

(2010) Stacy E.F. Melanson et al.   AMERICAN JOURNAL OF HEMATOLOGY

Cyclophosphamide and cancer: golden anniversary

(2009) Ashkan Emadi et al.   Nature Reviews Clinical Oncology

Influence of polymorphisms of drug metabolizing enzymes (CYP2B6, CYP2C9, CYP2C19, CYP3A4, CYP3A5, GSTA1, GSTP1, ALDH1A1 and ALDH3A1) on the pharmacokinetics of cyclophosphamide and 4-hydroxycyclophosphamide

(2008) Corine Ekhart et al.   Pharmacogenetics and Genomics